CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2021-05-12 | CONWAY ROBERT E Director | Purchase | +10,000 | $3.19 | $32K | 50,000 |
| 2021-05-05 | CONWAY ROBERT E Director | Purchase | +10,000 | $3.23 | $32K | 40,000 |
| 2021-01-12 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-12-18 | CONWAY ROBERT E Director | Purchase | +10,000 | $4.16 | $42K | 30,000 |
| 2020-09-25 | CONWAY ROBERT E Director | Purchase | +5,000 | $4.28 | $21K | 20,000 |
| 2020-09-22 | CONWAY ROBERT E Director | Purchase | +3,056 | $4.66 | $14K | 15,000 |
| 2020-09-21 | CONWAY ROBERT E Director | Purchase | +10,000 | $4.77 | $48K | 11,944 |
| 2018-03-01 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2017-07-14 | CONWAY ROBERT E Director | Purchase | +10,000 | $2.49 | $25K | 35,000 |
| 2017-03-24 | CONWAY ROBERT E Director | Purchase | +25,000 | $2.59 | $65K | 25,000 |
| 2017-02-16 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2016-02-11 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2015-02-12 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2014-02-11 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2013-09-17 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +14,750 | 14,750 | ||
| 2013-09-17 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +2,608 | 2,608 |
Page 1 of 1 · 18 trades